FibroGen
FGEN
FGEN
70 hedge funds and large institutions have $18.9M invested in FibroGen in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 30 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
63% less capital invested
Capital invested by funds: $50.4M → $18.9M (-$31.6M)
84% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 38
Holders
70
Holding in Top 10
1
Calls
$248K
Puts
$291K
Top Buyers
| 1 | +$578K | |
| 2 | +$542K | |
| 3 | +$307K | |
| 4 |
Renaissance Technologies
New York
|
+$301K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$216K |
Top Sellers
| 1 | -$1.5M | |
| 2 | -$1.18M | |
| 3 | -$853K | |
| 4 |
PI
Pennant Investors
Summit,
New Jersey
|
-$686K |
| 5 |
Millennium Management
New York
|
-$455K |